# Tissuetech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tissuetech

- Industry: Biotechnology
- Headquarters: Miami, US
- Website: www.tissuetech.com
- Total disclosed funding: $108M
- Latest round: Series C (Apr 9, 2019)
- Investors on record: 3

## About

Tissuetech, Inc. is a biotechnology company focused on developing innovative regenerative healing solutions utilizing proprietary technologies to enhance tissue repair and recovery in various medical fields.Founded in 2001 and headquartered in Miami, US, Tissuetech, Inc. specializes in regenerative medicine solutions. The company raised USD 82.25 mn in Series C funding in April 2019, led by Essex Woodlands with participation from Ballast Point Ventures. Amy Tseng is the founder, and Ted Davis serves as the CEO.Tissuetech specializes in advanced regenerative healing solutions through its CryoTek® technology, preserving the structure and biological properties of human birth tissue allografts. Its core products include Prokera, AmnioGraft, AmnioGuard, and Neox, primarily used in ophthalmology and surgical settings to support tissue repair and regeneration. The company serves healthcare providers, hospitals, and surgical centers across the US and selected regions in Europe and Asia.Tissuetech generates revenue through direct sales of its regenerative medicine products to healthcare facilities and practitioners. The revenue model focuses on B2B partnerships with hospitals and medical organizations that utilize its allografts in clinical settings, with products priced to reflect their therapeutic benefits and market demand.Tissuetech plans to introduce upcoming products designed to enhance tissue regeneration solutions. The company is targeting expansion into specific markets in Europe and Asia by 2025. The recent funding of USD 82.25 mn from the Series C round will support these initiatives, including product development and market entry strategies.

## Funding rounds

- Series C, Apr 9, 2019, $82M — Ballast Point Ventures, Essex Woodlands
- Series B, Jun 15, 2015, $15M — Ballast Point Ventures, RC Capital
- Series A, Oct 10, 2013, $0.4M — Ballast Point Ventures, RC Capital
- Series A, Aug 22, 2013, $10M — Ballast Point Ventures, RC Capital

## Investors

- Ballast Point Ventures (https://capitalatlas.ai/funds/ballast-point-ventures) — Series A, Series B, Series C
- RC Capital (https://capitalatlas.ai/funds/rc-capital) — Series A, Series B
- Essex Woodlands (https://capitalatlas.ai/funds/essex-woodlands) — Series C